Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity.
In cystic fibrosis (CF), lung damage is mediated by a cycle of obstruction, infection, inflammation and tissue destruction. The complement system is a major mediator of inflammation for many diseases with the effectors C5a and C3a often playing important roles. We have previously shown in a small pi...
Main Authors: | Pamela S Hair, Laura A Sass, Turaj Vazifedan, Tushar A Shah, Neel K Krishna, Kenji M Cunnion |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5344399?pdf=render |
Similar Items
-
Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease.
by: Laura A Sass, et al.
Published: (2015-01-01) -
Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1).
by: Pamela S Hair, et al.
Published: (2017-01-01) -
Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1
by: Pamela S. Hair, et al.
Published: (2018-03-01) -
Peptide inhibitor of complement C1 (PIC1), a novel suppressor of classical pathway activation: mechanistic studies and clinical potential
by: Julia A Sharp, et al.
Published: (2014-08-01) -
Classical complement pathway inhibition reduces brain damage in a hypoxic ischemic encephalopathy animal model.
by: Parvathi Kumar, et al.
Published: (2021-01-01)